REFERENCES
- Calle EE, Thun MJ, Petrelli JM, Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341:1097–1105.
- Buchwald H, Avidor Y, Braunwald E, Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–1737.
- Adams TD, Gress RE, Smith SC, Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–761.
- Livingston EH. Procedure incidence and in-hospital complication rates of bariatric surgery in the United States. Am J Surg. 2004;188:105–110.
- Campos CD, Dalcanale L, Pajecki D, Calcium intake and metabolic bone disease after eight years of Roux-en-Y gastric bypass. Obes Surg. 2008; 18:386–390.
- Martinsen TC, Bergh K, Waldum HL. Gastric juice: a barrier against infectious diseases. Basic Clin Pharmacol Toxicol. 2005; 96: 94–102.
- Livingston EH. Complications of bariatric surgery. Surg Clin North Am. 2005; 85:853–868.
- Chacon DA, Araújo-Filho I, Villarim-Neto A, Biodistribution of the radiophamarceutical sodium pertechnetate (Na99mTcO4) after massive small bowel resection in rats. Acta Cir Bras. 2007;22:430–435.
- Moreno SRF, Carvalho JJ, Nascimento AL, Bioavailability of the sodium pertechnetate and morphometry of organs isolated from rats: study of possible pharmacokinetic interactions of a Ginkgo biloba extract. Braz Arch Biol Technol. 2005;48:73–78.
- Xavier-Holanda CMC, Jales RLC, Catanho MTJA, Effects of the glucantime on the kinetic of biodistribution of radiopharmaceuticals in Wistar rats. Cell Mol Biol. 2002;48:761–765.
- Rêgo AC, Villarim Neto A, Azevedo IM, Biodistribution of Technetium-99m pertechnetate after total gastrectomy and Roux-en-Y jejunal pouch. J Invest Surg. 2010;23:94–100.
- Hutter MM, Randall S, Khuri SF, Laparoscopic versus open gastric bypass for morbid obesity: a multicenter, prospective, risk-adjusted analysis from the National Surgical Quality Improvement Program. Ann Surg. 2006;243:657–662.
- Leea CW, Kellyb JJ, Wassef WY. Complications of bariatric surgery. Curr Opin Gastroenterol. 2007;23:636–643.
- Macgregor AM, Pickens NE, Thoburn EK. Perforated peptic ulcer following gastric bypass for obesity. Am Surg. 1999;65:222–225.
- Lord RV, Edwards PD, Coleman MJ. Gastric cancer in the bypassed segment after operation for morbid obesity. Aust N Z J Surg. 1997;67:580–582.
- Nickel, RA. Radiopharmaceuticals. In: Principles and Practice of Nuclear Medicine, 2nd ed. Early, PJ, Sodee, DB, eds. London: Mosby Year Book Inc.; 1995: 94–114.
- Bernardo-Filho M, Silva JRM, Reis RJN, Conditions for labeling of Schistosoma mansoni cercaria with technetium-99m. J Nucl Biol Med. 1992;36:56–59.
- Braga ACS, Oliveira MBN, Feliciano GD, The effect of drugs on the labeling of blood elements with Technetium-99m. Curr Pharm Design. 2000;6:1179–1191.
- Gonzalez R, Sarr MG, Smith CD, Diagnosis and contemporary management of anastomotic leaks after gastric bypass for obesity. J Am Coll Surg. 2007;204:47–55.
- Tarakji AM, Morales F, Rovito P. Hepatobiliary scintigraphy as a diagnostic modality for gastroparesis of the bypassed stomach after gastric bypass for morbid obesity. Obes Surg. 2007;17:414–415.
- Madan AK, Orth WS, Tichansky DS, Ternovits CA. Vitamin and trace mineral levels after laparoscopic gastric bypass. Obes Surg. 2006;16:603–606.
- Goode LR, Brolin RE, Chowdhury HA, Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obes Res. 2004;12:40–47.
- Johnson JM, Maher JW, DeMaria EJ, The long-term effects of gastric bypass on vitamin D metabolism. Ann Surg. 2006;243:701–704.
- Johnson JM, Maher JW, Samuel I, Effects of gastric bypass procedures on bone mineral density, calcium, parathyroid hormone, and vitamin D. J Gastrointest Surg. 2005;9:1106–1110.
- Dixon JB, Bhathal PS, O'Brien PE. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Obes Surg. 2006;16:1278–1286.
- Nguyen NT, Bradley S, Fleming NW, Comparison of postoperative hepatic function after laparoscopic versus open gastric bypass. Am J Surg. 2003;186:40–44.
- Ishida RK, Faintuch J, Paula AM, Microbial flora of the stomach after gastric bypass for morbid obesity. Obes Surg. 2007;17:752–758.
- Westwater C, Schofield DA, Nicholas PJ, Candida glabrata and Candida albicans: dissimilar tissue tropism and infectivity in a gnotobiotic model of mucosal candidiasis. FEMS Immunol Med Microbiol. 2007;51:134–139.
- Sundbom M, Nyman R, Hedenström H, Investigation of the excluded stomach after Roux-en-Y gastric bypass. Obes Surg. 2001;11:25–27.
- Safatle-Ribeiro AV, Kuga R, Iriya K, What to expect in the excluded stomach mucosa after vertical banded Roux-en-Y gastric bypass for morbid obesity. J Gastrointest Surg. 2007; 11:133–137.